MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease
MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease
Not yet recruiting · NCT06788340 · Registry updated 2025-07-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease | Crohn disease, Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Not yet recruiting | Phase 4 | 2025-07-31 | NCT06788340 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Odense University Hospital | 253 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dept. of Gastrointestinal Diseases | Hvidovre | Denmark | 1 |
| Dept. of Gastrointestinal Diseases | Odense | Denmark | 1 |
| Dept. of Gastrointestinal Diseases | Aalborg | Denmark | 1 |
| Dept. of Internal Medicin | Esbjerg | Denmark | 1 |
| Dept. of Medicine | Vejle | Denmark | 1 |
| Dept. of medicine | Nyborg | Denmark | 1 |